Eukaryotic translation initiation factor 1 pseudogene 4 (EIF1P4)

Eukaryotic translation initiation factor 1 pseudogene 4 is a human pseudogene belonging to the EIF1 family but does not encode a functional translation initiation factor. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or lack of regulatory elements. Unlike active translation initiation factors (such as EIF1, EIF4A, or EIF4E), EIF1P4 is a non-coding genomic segment with no demonstrated biological activity, druggability, or disease relevance. It is generally excluded from therapeutic or biomarker consideration and may only possess minor roles in gene regulation, such as acting as competing endogenous RNA, but such functions have not been substantiated or widely described in scientific literature[3]. Key distinctions: EIF1P4 is distinct from functional translation initiation factors such as EIF1, EIF4A, or EIF4E, which are active roles in mRNA translation, cellular proliferation, and have relevance to cancer and other diseases[1][2]. EIF1P4 does not encode any protein or participate in translation, signaling, apoptosis, immune response, or cell cycle regulation. There is no evidence for drugs, safety issues, or biomarker uses related to EIF1P4. Summary: EIF1P4 ("Eukaryotic translation initiation factor 1 pseudogene 4") is a human pseudogene and not a real molecular target; it has no therapeutic, biological, or biomarker relevance, and is likely included by mistake if considered a drug target or functional receptor[3].

Other names

EIF1P4